LINC02339

Across TCGA pan-cancer cohorts, LINC02339 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC02339 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02339 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02339 expression acts as an unfavorable survival marker, although some lineages such as LGG and UCS show a favorable association.

BLCA, THYM, and LGG are the cancer types where LINC02339 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.051	0.720	<.001	144	view →
THYM	OS	Tertile	All	0.787	0.981	<.001	78	view →
LGG	DFS	Median	All	0.823	0.653	<.001	53	view →
READ	DFS	Tertile	III,IV	0.082	0.746	<.001	51	view →
UCS	OS	Tertile	II,III,IV	1.000	0.331	.023	48	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
OV	OS	Tertile	IV	0.022	0.760	<.001	36	view →
UCEC	DFS	Tertile	All	0.740	0.900	.006	36	view →
KIRC	DFS	Tertile	IV	0.166	0.619	.032	18	view →
ESCA	OS	Tertile	III,IV	0.130	0.574	.011	18	view →
PAAD	DFS	Tertile	All	1.000	0.262	.012	15	view →
PCPG	OS	Tertile	All	0.944	1.000	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC02339–BLCA (OS)

Open the BLCA breakdown →